AtriCure
ATRC
55.39
+1.28
+2.37%
AtriCure
US · ATRC
#2543 by market cap
Listed 1970
55.39
+1.28
+2.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About AtriCure
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
- Founded
- 2000
- CEO
- Mr. David J. Drachman
- Employees
- 1,350
- Headquarters
- Mason, Ohio, United States of America
- Fiscal year end
- 12-31
- Website
- atricure.com
Company profile
- Exchange
- US
- Symbol
- ATRC
- Market-cap rank
- #2543
- Listing date
- 1970-01-01
- Market cap
- 2.82B
- Float cap
- 2.71B
- Shares out
- 50.92M
- Float shares
- 48.88M
Sectors & themes
Medical Instruments & Supplies
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
AtriCure discussion 0 comments